✦ LIBER ✦

Should High-Dose Interleukin-2 Still Be the Preferred Treatment for Patients with Metastatic Melanoma?

✍ Scribed by Dillman, Robert O.; Barth, Neil M.; VanderMolen, Louis A.; Mahdavi, Khosrow; McClure, Stephanie E.

Book ID: 121395959
Publisher: Mary Ann Liebert
Year: 2012
Tongue: English
Weight: 263 KB
Volume: 27
Category: Article
ISSN: 1084-9785
DOI: 10.1089/cbr.2012.1220

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel immunoregulatory regimen combini

A novel immunoregulatory regimen combining high dose interleukin-2 and taurolidine for the treatment of patients with progressive metastatic melanoma

✍ G. C. O’Brien; R. A. Cahill; M. J. O’Sullivan; D. J. Bouchier-Hayes; H. P. Redmo 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 242 KB

Comparison of acute toxicity and mortali

Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma

✍ Laura M. Alwan, Kenneth Grossmann, Daniel Sageser, Joan Van Atta… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Phase II trial of recombinant human inte

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: Implications for the treatment of patients with metastatic melanoma

✍ Omar Eton; Moshe Talpaz; Kyoo H. Lee; Jeanne M. Rothberg; Joanna M. Brell; Rober 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

Prospective Randomized Trial of High-Dos

Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer

✍ Rosenberg, S. A.; Lotze, M. T.; Yang, J. C.; Topalian, S. L.; Chang, A. E.; Schw 📂 Article 📅 1993 🏛 Oxford University Press 🌐 English ⚖ 962 KB

Chemoimmunotherapy with dacarbazine, cis

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

✍ C.J.A. Punt; S. Suciu; M.A. Gore; J. Koller; W.H.J. Kruit; J. Thomas; P. Patel; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 150 KB

High-dose interleukin-2 for the treatmen

High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : A retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006

✍ Jacob A. Klapper; Stephanie G. Downey; Franz O. Smith; James C. Yang; Marybeth S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views